BE818990A - Nouvelles pyrimidines - Google Patents

Nouvelles pyrimidines

Info

Publication number
BE818990A
BE818990A BE147737A BE147737A BE818990A BE 818990 A BE818990 A BE 818990A BE 147737 A BE147737 A BE 147737A BE 147737 A BE147737 A BE 147737A BE 818990 A BE818990 A BE 818990A
Authority
BE
Belgium
Prior art keywords
new pyrimidines
pyrimidines
new
Prior art date
Application number
BE147737A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE818990A publication Critical patent/BE818990A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A63—SPORTS; GAMES; AMUSEMENTS
    • A63C—SKATES; SKIS; ROLLER SKATES; DESIGN OR LAYOUT OF COURTS, RINKS OR THE LIKE
    • A63C19/00—Design or layout of playing courts, rinks, bowling greens or areas for water-skiing; Covers therefor
    • A63C19/02—Shaping of the surface of courts according to the necessities of the different games

Landscapes

  • Engineering & Computer Science (AREA)
  • Architecture (AREA)
  • Civil Engineering (AREA)
  • Structural Engineering (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE147737A 1973-08-20 1974-08-19 Nouvelles pyrimidines BE818990A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732341925 DE2341925A1 (de) 1973-08-20 1973-08-20 Neue pyrimidinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
BE818990A true BE818990A (fr) 1975-02-19

Family

ID=5890167

Family Applications (1)

Application Number Title Priority Date Filing Date
BE147737A BE818990A (fr) 1973-08-20 1974-08-19 Nouvelles pyrimidines

Country Status (4)

Country Link
JP (1) JPS5049288A (fr)
BE (1) BE818990A (fr)
DE (1) DE2341925A1 (fr)
ZA (1) ZA745305B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075305A (en) * 1991-03-18 1991-12-24 Warner-Lambert Company Compound, composition and use
US5098902A (en) * 1991-03-18 1992-03-24 Warner-Lambert Company Method of treating neurodegenerative diseases

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1172255A (fr) * 1980-12-11 1984-08-07 Robert R. Covington Methode de preparation de buspirone
JPH0635450B2 (ja) * 1984-03-16 1994-05-11 三井東圧化学株式会社 チオシアノピリミジン誘導体、その製造法および農園芸用殺菌剤
US5658923A (en) * 1992-09-18 1997-08-19 Asahi Kasei Kogyo Kabushiki Kaisha Azepine derivatives and use thereof
ES2146614T3 (es) * 1992-09-18 2000-08-16 Asahi Chemical Ind Derivados de azepina, produccion de los mismos y su utilizacion como ligandos del receptor sigma.
CA2208900C (fr) * 1996-07-18 2006-08-01 Lonza Ag Methode de preparation de pyrimidine-2-carboxylates
IL137922A0 (en) 1998-02-17 2001-10-31 Tularik Inc Anti-viral pyrimidine derivatives
US6410726B1 (en) 2000-01-12 2002-06-25 Tularik Inc. Arylsulfonic acid salts of pyrimidine-based antiviral
ES2375111T3 (es) 2002-11-21 2012-02-24 Novartis Ag Pirimidinas 2,4,6-trisustituidas como inhibidores de fosfotidilinositol (pi) 3-quinasa y su uso en el tratamiento de c�?ncer.
NZ540612A (en) * 2003-01-14 2008-02-29 Arena Pharm Inc 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
EP1927594A1 (fr) * 2003-01-14 2008-06-04 Arena Pharmaceuticals, Inc. Dérivés d'aryle et d'hétéroaryle 1,2,3-trisubstitués en tant que modulateurs du métabolisme et la prévention et le traitement de maladies liées à celui-ci, telles que le diabète et l'hyperglycémie
TW200519094A (en) 2003-07-02 2005-06-16 Vertex Pharma Pyrimidines useful as modulators of voltage-gated ion channels
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
WO2005011655A2 (fr) 2003-07-30 2005-02-10 Xenon Pharmaceuticals Inc. Derives de pyridazine et leur utilisation en tant qu'agents therapeutiques
ATE532772T1 (de) 2003-07-30 2011-11-15 Xenon Pharmaceuticals Inc Piperazinderivate und deren verwendung als therapeutische mittel
HUP0400405A3 (en) * 2004-02-10 2009-03-30 Sanofi Synthelabo Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
JP2007217282A (ja) * 2004-03-04 2007-08-30 Astellas Pharma Inc 置換ピリミジン誘導体
US8071603B2 (en) 2004-09-20 2011-12-06 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
WO2006034341A2 (fr) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation en tant qu'agents therapeutiques
CA2580787A1 (fr) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et utilisation de ceux-ci comme agents therapeutiques
EP1799668A1 (fr) 2004-09-20 2007-06-27 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation en tant que modulateurs de stearoyle-coa desaturase
BRPI0515488A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados de heterocìclicos e seu uso como agentes terapêuticos
US7592343B2 (en) 2004-09-20 2009-09-22 Xenon Pharmaceuticals Inc. Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
JP4958786B2 (ja) 2004-09-20 2012-06-20 ゼノン・ファーマシューティカルズ・インコーポレイテッド 複素環誘導体および治療薬としてのそれらの使用
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
EP1904491A2 (fr) 2005-05-31 2008-04-02 Vertex Pharmaceuticals Incorporated Heterocycles utiles comme modulateurs de canaux ioniques
BRPI0611187A2 (pt) 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
GB0512844D0 (en) * 2005-06-23 2005-08-03 Novartis Ag Organic compounds
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
CA2675558A1 (fr) 2007-02-06 2008-08-14 Novartis Ag Inhibiteurs de la pi3-kinase et procedes de leur utilisation
WO2009038974A1 (fr) 2007-09-20 2009-03-26 Irm Llc Composés et compositions en tant que modulateurs de l'activité de gpr119
KR20110002465A (ko) * 2008-03-31 2011-01-07 젠야쿠코교가부시키가이샤 세포 보호 작용을 갖는 피리미딘 유도체 및 그 용도
ES2623794T3 (es) * 2008-12-09 2017-07-12 Gilead Sciences, Inc. Intermedios para la preparación de moduladores de receptores tipo toll
EP2619198A1 (fr) 2010-09-22 2013-07-31 Arena Pharmaceuticals, Inc. Modulateurs du récepteur gpr119 et traitement des troubles qui lui sont liés
EP2771337B1 (fr) 2011-09-27 2017-08-02 Novartis AG 3-(pyrimidin-4-yl)-oxazolidin-2-ones comme inhibiteurs d'idh mutante
CN103204816B (zh) 2012-01-16 2016-04-27 中国人民解放军军事医学科学院毒物药物研究所 哌嗪基嘧啶类衍生物及其制备方法和用途
UY34632A (es) 2012-02-24 2013-05-31 Novartis Ag Compuestos de oxazolidin- 2- ona y usos de los mismos
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
EP2970240B1 (fr) 2013-03-14 2018-01-10 Novartis AG 3-pyrimidin-4-yl-oxazolidin-2-ones comme inhibiteurs d'idh mutante
EP4445956A2 (fr) 2015-01-06 2024-10-16 Arena Pharmaceuticals, Inc. Composé pour le traitement des affections associés à s1p1-récepteur
WO2016209809A1 (fr) 2015-06-22 2016-12-29 Arena Pharmaceuticals, Inc. Sel l-arginine cristallin d'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclo-penta[b]indol-3-yl)acétique (composé 1) pour une utilisation dans des troubles associés au récepteur de s1p1
WO2018151873A1 (fr) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Composés et méthodes de traitement de l'angiocholite biliaire primitive

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075305A (en) * 1991-03-18 1991-12-24 Warner-Lambert Company Compound, composition and use
US5098902A (en) * 1991-03-18 1992-03-24 Warner-Lambert Company Method of treating neurodegenerative diseases

Also Published As

Publication number Publication date
ZA745305B (en) 1976-04-28
JPS5049288A (en) 1975-05-01
DE2341925A1 (de) 1975-03-06

Similar Documents

Publication Publication Date Title
BE818990A (fr) Nouvelles pyrimidines
AT338352B (de) Ohrstuck
AT325093B (de) Trittbahn
AT359180B (de) Osteotom
BE813158A (fr) Nouvelles benzoquinolizines
FI56432B (fi) Gaskolv i skjutvapen
BE814229A (fr) Nouvelles azolylamidines
BE813142A (fr) Nouvelles piperazines disubstituees
AT329420B (de) Monoschi
AT325408B (de) Stoffloser
BE819773A (fr) Nouvelles benzylpyrimidines
FR2295005A1 (fr) Nouvelles substances odoriferantes
DOP1974002166A (es) Antilidas heterociclicas
AT342382B (de) Flussmittel
BE813677A (fr) Nouvelles triazolo-1
BE817294A (fr) Nouvelles sulfonyloxyphenylurees
AT354042B (de) Raffstore
ATA280876A (de) Fugizid
BE793744A (fr) Gewapend bouwpaneel
BE818131A (fr) Nouvelles benzylpyrimidines
BE810364A (fr) Nouvelles benzoylphenylguanidines
BE813947A (fr) Nouvelles dichlorothiazolylurees
BE821477A (fr) Nouvelles penicillines
IT1054123B (it) Fosfoserinato di piridossina
AT323390B (de) Türstock